Clinical Trial: A Study on the Efficacy and Safety of Microneedling for Male Androgenetic Alopecia

U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07758400) titled 'A Study on the Efficacy and Safety of Microneedling for Male Androgenetic Alopecia' on Aug. 06.

Brief Summary: Androgenetic alopecia (AGA) is the most prevalent hair-loss disorder in clinical practice. With a high incidence rate, it not only severely impairs patients' appearance and quality of life, but may also trigger varying degrees of depression and compromise mental health, highlighting the critical importance of standardized management for AGA. Current therapeutic options for AGA include oral finasteride, topical minoxidil, physical therapies and others. Nevertheless, safety concerns over oral medications remain prominent. Fin...